Reported positive results from the Expanded Access Protocol (NEXT), reinforcing NexoBrid's clinical and real-world benefits across 29 burn centers in the U.S. The study included 239 patients (215 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback